Hypothesis: Microbiome‑Driven Urolithin A/Phenylacetic Acid Ratio Determines Mitophagy Efficiency and Inflammaging
Core idea Urolithin A (UA) stimulates mitophagy via PINK1/Parkin activation and AMPK‑ULK1 signaling, while phenylacetic acid (PAA) promotes endothelial senescence and mitochondrial H₂O₂ production. We propose that the UA : PAA plasma ratio, shaped by individual gut microbiome composition, predicts the net effect on mitochondrial quality control and systemic inflammation. A high ratio yields enhanced mitophagy, reduced ROS, and improved CD8⁺ T‑cell naïvity; a low ratio blunts UA benefits and accelerates inflammaging.
Novel mechanistic insight UA restores ER‑mitochondria‑lysosome calcium signaling, a process that PAA‑induced oxidative stress disrupts by oxidizing ER calcium‑release channels (IP₃R) and lysosomal TRPML1. When UA predominates, calcium fluxes rebound, facilitating autophagosome‑lysosome fusion and mitophagy completion. Conversely, excess PAA sustains ER stress, blocks calcium‑dependent ULK1 recruitment, and shifts autophagy toward incomplete flux, thereby converting UA’s mitophagy signal into a futile cycle.
Testable predictions
- In a cohort of middle‑aged adults, baseline plasma UA : PAA ratio will correlate positively with mitophagy markers (LC3‑II/I, PINK1 accumulation) in isolated PBMCs and negatively with senescence‑associated secretory phenotype (SASP) cytokines (IL‑6, IL‑8, TNF‑α).
- Four‑week supplementation with 1000 mg/day UA will increase the UA : PAA ratio only in participants whose baseline microbiota harbor hi





























